Stockholm – October 15, 2026 -- The US National Institutes of Health (NIH) has selected SciBase Holding AB's Nevisense electrical impedance spectroscopy (EIS) technology as the primary endpoint in its THREAT study, which will test how environmental exposures affect the skin barrier in 80 healthy volunteers.
